LONDON, England, Nov. 13 [Category: BizPharmaceuticals] -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

Bexsero (4CMenB) receives positive CHMP opinion for one-dose Meningitis B booster for 10+ year olds

*

* Recommendation based on data showing immune memory established following vaccination in infancy can be boosted up to 19 years later1

* Once approved, the single-dose boos . . .

Click here for more information about our products